Mass Production and Size Control of Lipid–Polymer Hybrid Nanoparticles through Controlled Microvortices-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Mass Production and Size Control of Lipid–Polymer Hybrid Nanoparticles through Controlled Microvortices

Published:2012-06-20 Issue:7 Volume:12 Page:3587-3591
ISSN:1530-6984
Container-title:Nano Letters
language:en
Short-container-title:Nano Lett.

Author:

Kim YongTae,Lee Chung Bomy,Ma Mingming,Mulder Willem J. M.¹,Fayad Zahi A.¹,Farokhzad Omid C.²,Langer Robert

Affiliation:

1. Translational and Molecular Imaging Institute, Mount Sinai School of Medicine, One Gustave L. Levy Place, Box 1234, New York, 10029, United States

2. Department of Anesthesiology, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts 02115, United States

Publisher

American Chemical Society (ACS)

Subject

Mechanical Engineering,Condensed Matter Physics,General Materials Science,General Chemistry,Bioengineering

Link

https://pubs.acs.org/doi/pdf/10.1021/nl301253v

Reference30 articles.

1. Nanoprecipitation and nanoformulation of polymers: from history to powerful possibilities beyond poly(lactic acid)

2. Polymeric Nanoparticles for Drug Delivery

3. Self-Assembled Targeted Nanoparticles: Evolution of Technologies and Bench to Bedside Translation

4. Self-Assembled Lipid−Polymer Hybrid Nanoparticles: A Robust Drug Delivery Platform

5. PLGA–lecithin–PEG core–shell nanoparticles for controlled drug delivery

Cited by 200 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lipid polymer hybrid nanoparticles against lung cancer and their application as inhalable formulation;Nanomedicine;2024-08-15

2. Advancements in Nanoparticle-Based Strategies for Enhanced Antibacterial Interventions;Cell Biochemistry and Biophysics;2024-07-18

3. Lipid Nanoparticles in Lung Cancer Therapy;Pharmaceutics;2024-05-10

4. Nanotechnology-based delivery systems to overcome drug resistance in cancer;Medical Review;2024-02-01

5. Neoantigen vaccine nanoformulations based on Chemically synthesized minimal mRNA (CmRNA): small molecules, big impact;npj Vaccines;2024-01-18

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3